Search

everythinglearnresearchcommunity

for

Search:↓

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

A boy with long QT syndrome was treated successfully, highlighting the need for careful evaluation of chest pain in children for heart conditions like LQTS.

Genomics can improve patient care by using DNA to create personalized treatment plans.

South American camelids should be sheared early, fleece type affects fiber quality, and the S/P follicle ratio doesn't distinguish between Bolivian llama genotypes.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Using finasteride with TIP extends time off period for prostate cancer patients.

SkQ1 antioxidant improved health and lifespan in mice.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Pexidartinib often causes liver issues and fatigue, especially in women.

CTP-543 is generally safe for treating alopecia areata.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

The new technique PÂTÉ improved the amount of scalp tissue removed in surgeries.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

FLRG and follistatin have different roles in wound healing.

QLT0267 stops hair follicle cell growth and movement.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

PRP injections with tadalafil and stretching safely improved Peyronie's symptoms but didn't significantly change curvature long-term.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.